Research
The Enhancing Secondary Prevention in Coronary Artery Disease trial
Finlay A. McAlister, Miriam Fradette, Sumit R. Majumdar, Randall Williams, Michelle Graham, James McMeekin, William A. Ghali, Ross T. Tsuyuki, Merril L. Knudtson and Jeremy Grimshaw
CMAJ December 08, 2009 181 (12) 897-904; DOI: https://doi.org/10.1503/cmaj.090917
Finlay A. McAlister
Miriam Fradette
Sumit R. Majumdar
Randall Williams
Michelle Graham
James McMeekin
William A. Ghali
Ross T. Tsuyuki
Merril L. Knudtson
Data supplements
Online Appendix
Files in this Data Supplement:
Related Articles
- (2009). Highlights. CMAJ, 181(12), 873. Accessed April 18, 2024. Retrieved from http://www.cmaj.ca/content/181/12/873.
In this issue
Article tools
Respond to this article
The Enhancing Secondary Prevention in Coronary Artery Disease trial
Finlay A. McAlister, Miriam Fradette, Sumit R. Majumdar, Randall Williams, Michelle Graham, James McMeekin, William A. Ghali, Ross T. Tsuyuki, Merril L. Knudtson, Jeremy Grimshaw
CMAJ Dec 2009, 181 (12) 897-904; DOI: 10.1503/cmaj.090917
The Enhancing Secondary Prevention in Coronary Artery Disease trial
Finlay A. McAlister, Miriam Fradette, Sumit R. Majumdar, Randall Williams, Michelle Graham, James McMeekin, William A. Ghali, Ross T. Tsuyuki, Merril L. Knudtson, Jeremy Grimshaw
CMAJ Dec 2009, 181 (12) 897-904; DOI: 10.1503/cmaj.090917
Jump to section
Related Articles
Cited By...
- Enhancing prescribing of guideline-recommended medications for ischaemic heart diseases: a systematic review and meta-analysis of interventions targeted at healthcare professionals
- Association between in-hospital guideline adherence and postdischarge major adverse outcomes of patients with acute coronary syndrome in Vietnam: a prospective cohort study
- Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial
- A Cluster Randomized Trial of an Enhanced eGFR Prompt in Chronic Kidney Disease
- Why didn't it work?